Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Open-Label, Single-Arm Study to Evaluate the Effects of Vogelxo(R) on 24-hour Ambulatory Blood Pressure Monitoring in Hypogonadal Men Using Therapeutic Testosterone Replacement Therapy

NCT04558567 is registered in ClinicalTrials.gov with Upsher-Smith Laboratories as lead sponsor.

NCT NCT04558567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04558567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Open-Label, Single-Arm Study to Evaluate the Effects of Vogelxo(R) on 24-hour Ambulatory Blood Pressure Monitoring in Hypogonadal Men Using Therapeutic Testosterone Replacement Therapy
Lead sponsor
Upsher-Smith Laboratories
Phase
Phase 4
Overall status
Completed
Start date
August 28, 2020
Completion date
January 11, 2024
Enrollment
122 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, male